Innate immune adaptor TRIF confers neuroprotection in amyotrophic lateral sclerosis

April 17, 2018, Nagoya University
Abnormally activated astrocytes were accumulated in the lesion of ALS mouse without TRIF signaling, leading to accelerate motor neuron death. TRIF confers neuroprotection by eliminating abnormal astrocytes to maintain microenvironment surrounding motor neurons. Credit: Koji Yamanaka

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease damaging motor neurons in brain and spinal cords. ALS patients show progressive muscle weakness and atrophy, leading to a fatal respiratory muscle paralysis. There are no effective therapies for ALS.

There are compelling evidence that glial and immune cells contribute to the progression of neurodegenerative diseases including ALS. The has been implicated in disease processes of ALS, but it remains unknown if innate immune signaling also contributes to ALS progression.

Now, the research group led by Professor Koji Yamanaka at Nagoya University revealed that deficiency of the innate immune adaptor TRIF, which is essential for certain Toll-like receptor (TLR) signaling cascades, significantly shortened survival time of ALS .

To test the role of in the mouse model of ALS, the researchers focused on Toll-like receptors (TLR), which are important sensors for innate immunity. TLR signaling requires TRIF and MyD88, two critical adaptor proteins for transmitting signals. "We found that ablation of TRIF significantly shortens survival time of ALS mice," says Okiru Komine, first author of the study. "While MyD88 is also a crucial adaptor for most TLR signaling pathways, MyD88 deficiency had no impact on disease course."

In addition, they found that aberrantly activated astrocytes were accumulated in the lesions of TRIF-deficient ALS mice. Astrocytes, one type of glial cells are the supporting cells for survival and function of neurons in the brain by secreting many kinds of neuroprotective molecules. However, in the lesion of ALS, astrocytes change their shapes and some of them are abnormally activated to secrete the harmful molecules to the neurons.

These aberrantly activated astrocytes overproduced toxic reactive oxygens. Researchers found TRIF signaling is able to eliminate these aberrantly activated astrocytes by apoptosis, a suicide program of the cells. In the absence of TRIF, these astrocytes were accumulated. Moreover, the number of aberrantly activated astrocytes was negatively correlated with survival time of ALS mice, suggesting that these astrocytes are toxic to the motor neurons.

"These results revealed for the first time that the TRIF pathway is involved in eliminating aberrantly activated astrocytes to maintain the microenvironment surrounding motor neurons in ALS mice," Yamanaka says. "The current study reveals the new roles of innate immunity in ALS pathomechanism and provides a clue to develop a new therapeutic approach for protecting ALS motor ."

Explore further: Researchers study astrocyte cells that may contribute to ALS and Alzheimer's

More information: Okiru Komine et al, Innate immune adaptor TRIF deficiency accelerates disease progression of ALS mice with accumulation of aberrantly activated astrocytes, Cell Death & Differentiation (2018). DOI: 10.1038/s41418-018-0098-3

Related Stories

Researchers study astrocyte cells that may contribute to ALS and Alzheimer's

December 9, 2016
An achievement by UCLA neuroscientists could lead to a better understanding of astrocytes, a type of cell in the brain that is thought to play a role in Lou Gehrig's disease, also called amyotrophic lateral sclerosis, or ...

Brain astrocytes linked to Alzheimer's disease

November 20, 2017
Astrocytes, the supporting cells of the brain, could play a significant role in the pathogenesis of Alzheimer's disease (AD), according to a new study from the University of Eastern Finland. This is the first time researchers ...

Scientists use gene expression to understand how astrocytes change with age

January 11, 2018
Potentially explaining why even healthy brains don't function well with age, Salk researchers have discovered that genes that are switched on early in brain development to sever connections between neurons as the brain fine-tunes, ...

Conversion of brain cells offers hope for Parkinson's patients

April 11, 2017
Researchers at Karolinska Institutet have made significant progress in the search for new treatments for Parkinson's disease. By manipulating the gene expression of non-neuronal cells in the brain, they were able to produce ...

Helper cells in the brain could hold the clue to motor neuron disease

October 16, 2015
Helper cells in the brain, which support nerve function, change their behaviour with the progression of motor neuron disease (MND), a new study has found.

Recommended for you

Biomarkers and efficacy of vaccine responses among patients treated with new MS drug

April 26, 2018
In March 2017, the U.S. Food and Drug Administration approved ocrelizumab as the first treatment for both relapsing (RMS) and progressive forms of multiple sclerosis (MS), a genetic disease that afflicts approximately 400,000 ...

Noninvasive spinal stimulation method enables paralyzed people to regain use of hands, study finds

April 26, 2018
The ability to perform simple daily tasks can make a big difference in people's lives, especially for those with spinal cord injuries. A UCLA-led team of scientists reports that six people with severe spinal cord injuries—three ...

New link between sleep arousals and body temperature may also be connected to SIDS

April 25, 2018
Brief arousals during sleep—sometimes as many as ten to fifteen per night—appear random in time and occur in humans and even in animals.

Ethics debate overdue in human brain research: experts

April 25, 2018
What if human brain tissue implanted into a pig transferred some of the donor's self-awareness and memories?

Brain structure linked to symptoms of restless legs syndrome

April 25, 2018
People with restless legs syndrome may have changes in a portion of the brain that processes sensory information, according to a study published in the April 25, 2018, online issue of Neurology, the medical journal of the ...

Imaging may allow safe tPA treatment of patients with unwitnessed strokes

April 25, 2018
A study led by Massachusetts General Hospital (MGH) investigators may lead to a significant expansion in the number of stroke patients who can safely be treated with intravenous tPA (tissue plasminogen activator), the "clot ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.